Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 8, 1995, Pages 1086-1093

  Tornvall, Per ^a,b   Olivecrona, Gunilla ^c   Karpe, Fredrik ^b   Hamsten, Anders ^b   Olivecrona, Thomas ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

coronary heart disease; lipoprotein lipase; plasma lipoproteins

Indexed keywords

HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029086881     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.8.1086     Document Type: Article

References (56)

1. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 1989;320:1060-1068.
2. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. In: Schettler G, ed. Handbook of Pharmacology: Hypolipidemic Drugs. Heidelberg, Germany: Springer. In press.
3. Taskinen M-R, Kuusi T. Enzymes involved in triglyceride hydrolysis. In: Shepherd J, ed. Bailliere's Clinical Endocrinology and Metabolism: Lipoprotein Metabolism. London, UK: WB Saunders; 1987:639-666.
4. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb. 1992; 12:1176-1183.
5. Huttunen JK, Ehnholm C, Kekki M, Nikkilä EA. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med. 1976;50:249-260.
6. Taskinen M-R, Nikkilä EA, Kuusi T. Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity. Eur J Clin Invest. 1982;12:433-438.
7. Breier CH, Muhlberger V, Drexel H, Herold M, Lisch H-J, Knapp E, Braunsteiner H. Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease. Lancet. 1985;1:1242-1244.
8. Nozaki S, Kubo M, Sudo H, Matsuzava Y, Tarui S. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein: postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals. Metabolism. 1986;35:53-58.
9. Johansson J, Nilsson-Ehle P, Carlson LA, Hamsten A. The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. Atherosclerosis. 1991;86:111-122.
10. Applebaum-Bowden D, Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Postheparin plasma triglyceride lipases: relationships with very low-density lipoprotein triglyceride and high-density lipoprotein, cholesterol. Arteriosclerosis. 1985;5:273-282.
11. Kuusi T, Ehnholm C, Viikari J, Härkönen R, Vartiainen E, Puska P, Taskinen M-R. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res. 1989;30:1117-1126.
12. 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 1987;80:341-347.
13. Weintraub MS, Eisenberg S, Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J Clin Invest. 1987; 79:1110-1119.
14. Wilson DE, Emi M, Iverius P-H, Hata A, Wu LL, Hillas E, Williams RR, Lalouel J-M. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 1990;86: 735-750.
15. Olivecrona T, Bengtsson-Olivecrona G, Hultin M. Lipases in lipoprotein metabolism. In: Shepherd J, ed. Lipoproteins and the Pathogenesis of Atherosclerosis. Amsterdam, Netherlands: Elsevier; 1991;51-58.
16. Glaser DS, Yost TJ, Eckel RH. Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities. J Lipid Res. 1992;33:209-214.
17. Karpe F, Olivecrona T, Walldius G, Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res. 1992;33:975-984.
18. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci U S A. 1990;87:909-913.
19. Saxena U, Witte LD, Goldberg IJ. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem. 1989;264:4349-4355.
20. Saxena U, Klein MG, Goldberg IJ. Transport of lipoprotein lipase across endothelial cells. Proc Natl Acad Sci U S A. 1991;88:2254-2258.
21. Saxena U, Witte LD, Goldberg IJ. Tumor necrosis factor-induced release of endothelial cell lipoprotein lipase. Arteriosclerosis. 1990; 10:470-476.
22. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase: evidence for heparan sulphate proteoglycan-mediated internalization and recycling. J Biol Chem. 1990;265:12880-12886.
23. Sivaram P, Klein MG, Goldberg IJ. Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells. J Biol Chem. 1992;267:16517-16522.
24. Vilaro S, Llobera M, Bengtsson-Olivecrona G, Olivecrona T. Lipoprotein lipase uptake by liver: localization, turnover and metabolic role. Am J Physiol. 1988;254:G711-G722.
25. Mulder M, Lombardi P, Jansen H, van Berkel TJC, Frants RR, Havekes LM. Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. Biochem Biophys Res Commun. 1992;185:582-587.
26. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulphate on cell surfaces and extracellular matrix. J Clin Invest. 1992;90:2013-2021.
27. Williams KJ, Fless GM, Petrie KA, Snyder ML, Brocia RW, Swenson TL. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins: roles for low density lipoprotein receptors and heparan sulphate proteoglycans. J Biol Chem. 1992;267:13284-13292.
28. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci U S A. 1991;88:8342-8346.
29. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest. 1992;90: 1504-1512.
30. Ikeda Y, Takagi A, Ohkaru Y, Nogi N, Iwanga T, Kurooka S, Yamamoto A. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. J Lipid Res. 1990;31:1911-1924.
31. Goldberg IJ, Kandell JJ, Blum CB, Ginsberg HN. Association of plasma lipoproteins with postheparin lipase activities. J Clin Invest. 1986;78:1523-1528.
32. Vilella E, Joven J, Fernandez M, Vilaro S, Brunzell JD, Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res. 1993;34:1555-1564.
33. Hamsten A. Studies on Myocardial Infarction at Young Age: Metabolic, Haemostatic and Familial Factors in Post-Infarction Patients Below the Age of 45. Stockholm, Sweden: Karolinska Institute; 1986. Thesis.
34. Bengtsson-Olivecrona G, Olivecrona T. Phospholipase activity of milk lipoprotein lipase. In: Dennis EA, ed. Methods in Enzymology: Phospholipases. Orlando, Fla: Academic Press; 1991;197:345-356.
35. Zaidan H, Dhanireddy R, Hamosh M, Bengtsson-Olivecrona G, Hamosh P. Lipid clearing in premature infants during continuous heparin infusion: role of circulating lipases. Pediatr Res. 1985;19: 23-25.
36. Olivecrona T, Bengtsson G. Immunochemical properties of lipoprotein lipase: development of an immunoassay applicable to several mammalian species. Biochim Biophys Acta. 1983;752:38-45.
37. Liu M-S, Ma Y, Hayden MR, Brunzell JD. Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity. Biochim Biophys Acta. 1992;1128: 113-115.
38. Peterson J, Fujimoto WY, Brunzell JD. Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res. 1992;33:1165-1170.
39. Bengtsson-Olivecrona G, Olivecrona T. Assay of lipoprotein lipase and hepatic lipase. In: Skinner RE, Converse CA, eds. Lipoprotein Analysis: A Practical Approach. Practical Approach Series. Oxford, UK: Oxford University Press; 1992:169-185.
40. Carlson K. Lipoprotein fractionation. J Clin Pathol. 1973;26:32-37.
41. Zlatkis A, Zak B, Boyle A. A new method for direct determination of serum cholesterol. J Lab Clin. 1953;41:486-492.
42. Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968;22:393-397.
43. Carlson LA. Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform methanol. Clin Chim Acta. 1985;149:89-93.
44. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Ann Clin Biochem. 1969;6: 24-33.
45. Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance. Am J Med. 1976;60:80-88.
46. Östlund-Lindqvist AM, Boberg J. Purification of salt resistant lipase and lipoprotein lipase from human post-heparin plasma. FEBS Lett. 1977;83:231-236.
47. Hayashi R, Tajima S, Yamamoto A. Purification and characterization of lipoprotein lipase from human postheparin plasma and its comparison with purified bovine milk lipoprotein lipase. J Biochem. 1986;100:319-331.
48. Zechner R. Rapid and simple isolation procedure for lipoprotein lipase from human milk. Biochim Biophys Acta. 1990;1044:20-25.
49. Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramhorst E, Chin-On S, Hofman A, Cresswell SR, Havekes LM. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 1991; 11:653-662.
50. Simpson HS, Williamson CM, Olivecrona T, Pringle S, MacLean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 1990;85:193-202.
51. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 1993;91:748-758.
52. Miesenbock G, Patsch JR. Postprandial hyperlipemia: the search for the atherogenic lipoprotein. Curr Opin Lipidol. 1992;3:196-201.
53. Sniderman AD, Baldo A, Cianflone K. The potential role of acylation stimulating protein as a determinant of plasma triglyceride clearance and intracellular triglyceride synthesis. Curr Opin Lipidol. 1992;3:202-207.
54. Hata A, Ridinger DN, Sutherland SD, Emi M, Kwong LK, Shuhua J, Lubbers A, Guy-Grand B, Basdevant A, Iverius P-H, Wilson DE, Lalouel J-M. Missense mutations in exon 5 of the human lipoprotein lipase gene: inactivation correlates with loss of dimerization. J Biol Chem. 1992;267:20132-20139.
55. Stocks J, Thorn JA, Galton DJ. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res. 1992;33:853-857.
56. 447→a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun. 1992;182:70-77.